切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (03) : 282 -284. doi: 10.3877/cma.j.issn.1674-3253.2022.03.021

综述

经皮肾镜碎石取石术出血的预防和治疗
陈冠宇1, 李炯明1,(), 刘建和1, 王光1, 李沛1, 段飞1   
  1. 1. 650101 昆明,昆明医科大学第二附属医院泌尿外科
  • 收稿日期:2020-07-08 出版日期:2022-06-01
  • 通信作者: 李炯明

Prevention and treatment of nephrolithotripsy bleeding

Guanyu Chen1, Jiongming Li1(), Jianhe Liu1   

  • Received:2020-07-08 Published:2022-06-01
  • Corresponding author: Jiongming Li
引用本文:

陈冠宇, 李炯明, 刘建和, 王光, 李沛, 段飞. 经皮肾镜碎石取石术出血的预防和治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(03): 282-284.

Guanyu Chen, Jiongming Li, Jianhe Liu. Prevention and treatment of nephrolithotripsy bleeding[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(03): 282-284.

[1]
Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world[J]. World J Urol, 2017, 35(9): 1301-1320.
[2]
Khan SR, Pearle MS, Robertson WG, et al. Kidney stones[J]. Nat Rev Dis Primers, 2016, 2: 16008.
[3]
Türk C, Petřík A, Sarica K, et al. EAU guidelines on interventional treatment for urolithiasis[J]. Eur Urol, 2016, 69(3): 475-482.
[4]
Lee JK, Kim BS, Park YK. Predictive factors for bleeding during percutaneous nephrolithotomy[J]. Korean J Urol, 2013, 54(7): 448-453.
[5]
He X, Xie D, Du C, et al. Improved nephrostomy tube can reduce percutaneous nephrolithotomy postoperative bleeding[J]. Int J Clin Exp Med, 2015, 8(3): 4243-4249.
[6]
Turk C, Petrik A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis[J]. Eur Urol, 2016, 69(3): 468-474.
[7]
Ordon M, Urbach D, Mamdani M, et al. The surgical management of kidney stone disease: a population based time series analysis[J]. J Urol, 2014, 192(5): 1450-1456.
[8]
Ghani KR, Sammon JD, Bhojani N, et al. Trends in percutaneous nephrolithotomy use and outcomes in the United States[J]. J Urol, 2013, 190(2): 558-564.
[9]
Armitage JN, Withington J, van der Meulen J, et al. Percutaneous nephrolithotomy in england: practice and outcomes described in the hospital episode statistics database[J]. BJU Int, 2014, 113(5): 777-782.
[10]
Kadlec AO, Ellimoottil C, Guo R, et al. Contemporary volume-outcome relationships for percutaneous nephrolithotomy: results from the nationwide inpatient sample[J]. J Endourol, 2013, 27(9): 1107-1113.
[11]
Armitage JN, Irving SO, Burgess NA. Percutaneous nephrolithotomy in the United kingdom: results of a prospective data registry[J]. Eur Urol, 2012, 61(6): 1188-1193.
[12]
Keoghane SR, Cetti RJ, Rogers AE, et al. Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL) [J]. BJU Int, 2013, 111(4): 628-632.
[13]
Ghani KR, Andonian S, Bultitude M, et al. Percutaneous nephrolithotomy: update, trends, and future directions[J]. Eur Urol, 2016, 70(2): 382-396.
[14]
Bansal A, Arora A. A double-blind, placebo-controlled randomized clinical trial to evaluate the efficacy of tranexamic acid in irrigant solution on blood loss during percutaneous nephrolithotomy: a pilot study from tertiary care center of north india[J]. World J Urol, 2017, 35(8): 1233-1240.
[15]
Wein AJ, Kavoussi LR, Novick AC, et al. Campbell-Walsh Urology 10e[M]. Elsevier Saunders, 2012.
[16]
Mithani MH, Khan SA, Khalid SE, et al. Predictive factors for intraoperative blood loss during percutaneous nephrolithotomy[J]. J Coll Physicians Surg Pak, 2018, 28(8):623-627.
[17]
Said SHA, Al Kadum Hassan MA, Ali RHG, et al. Percutaneous nephrolithotomy; alarming variables for postoperative bleeding[J]. Arab J Urol, 2017, 15(1): 24-29.
[18]
Karalar M, Tuzel E, Keles I, et al. Effects of parenchymal thickness and stone density values on percutaneous nephrolithotomy outcomes[J]. Med Sci Monit, 2016, 22: 4363-4368.
[19]
Ganpule AP, Shah DH, Desai MR. Postpercutaneous nephrolithotomy bleeding: aetiology and management[J]. Curr Opin Urol, 2014, 24(2): 189-194.
[20]
Sahin C, Can U, Eryildirim B, et al. Transient cessation of antiplatelet medication before percutaneous stone surgery: does it have any safety concern on bleeding related problems? [J]. Urolithiasis, 2017, 45(4): 371-378.
[21]
Zumrutbas AE, Toktas C, Baser A, et al. Percutaneous Nephrolithotomy in Rare Bleeding Disorders: A Case Report and Review of the Literature[J]. J Endourol Case Rep, 2016, 2(1): 198-203.
[22]
Zehri AA, Biyabani SR, Siddiqui KM, et al. Triggers of blood transfusion in percutaneous nephrolithotomy[J]. J Coll Physicians Surg Pak, 2011, 21(3): 138-141.
[23]
Nouralizadeh A, Ziaee SAM, Hosseini Sharifi SH, et al. Delayed postpercutaneous nephrolithotomy hemorrhage: prevalence, predictive factors and management[J]. Scand J Urol, 2014, 48(1): 110-115.
[24]
Karakose A, Aydogdu O, Atesci YZ. Does the use of smaller Amplatz sheath size reduce complication rates in percutaneous nephrolithotomy? [J]. Urol J, 2014, 11(4): 1752-1756.
[25]
Shin TS, Cho HJ, Hong S-H, et al. Complications of percutaneous nephrolithotomy classified by the modified clavien grading system: a single center's experience over 16 years[J]. Korean J Urol, 2011, 52(11): 769-775.
[26]
Li L, Zhang Y, Chen Y, et al. A multicentre retrospective study of transcatheter angiographic embolization in the treatment of delayed haemorrhage after percutaneous nephrolithotomy[J]. Eur Radiol, 2015, 25(4): 1140-1147.
[27]
Ganpule AP, Shah DH, Ganpule SA, et al. Role of multi-detector computed tomography (MDCT) in management of post percutaneous nephrolithotomy (PCNL) bleeding[J]. F1000Research, 2013, 2: 253.
[28]
石鑫,陈戬. 经皮肾镜取石术并发肾出血的原因和防治进展[J]. 临床泌尿外科杂志, 2013, 28(10): 790-793.
[29]
Müller M, Rassweiler MC, Klein J, et al. Mobile augmented reality for computer-assisted percutaneous nephrolithotomy[J]. Int J Comput Assist Radiol Surg2013, 8(4): 663-675.
[30]
Li H, Chen Y, Liu C, et al. Construction of a three-dimensional model of renal stones: comprehensive planning for percutaneous nephrolithotomy and assistance in surgery[J]. World J Urol, 2013, 31(6): 1587-1592.
[31]
李炯明,王光,刘建和, 等. 集合系统CT三维重建精准指导经皮肾镜手术目标肾盏选择和穿刺的临床研究[J]. 临床外科杂志, 2017, 25(2): 107-110.
[32]
Palmerola R, Patel V, Hartman C, et al. Renal functional outcomes are not adversely affected by selective angioembolization following percutaneous nephrolithotomy[J]. Asian J Urol, 2017, 4(1): 27-30.
[33]
El Tayeb MM, Knoedler JJ, Krambeck AE, et al. Vascular complications after percutaneous nephrolithotomy: 10 years of experience[J]. Urology, 2015, 85(4): 777-781.
[34]
Ząbkowski T, Piasecki P, Zieliński H, et al. Superselective renal artery embolization in the treatment of iatrogenic bleeding into the urinary tract[J]. Med Sci Monit, 2015, 21: 333-337.
[35]
Un S, Cakir V, Kara C, et al. Risk factors for hemorrhage requiring embolization after percutaneous nephrolithotomy[J]. Can Urol Assoc J, 2015, 9(9-10): E594-E598.
[36]
Aminsharifi A, Irani D, Eslahi A. Massive hemorrhage after percutaneous nephrolithotomy: saving the kidney when angioembolization has failed or is unavailable[J]. Int J Surg, 2014, 12(8): 872-876.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[8] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[11] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[12] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[13] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?